Inventors and Innovators: Riyi Shi
His research contributions include originating the use of double sucrose gap technique for recording action potential conduction, establishing the methods of neuronal membrane resealing by polyethylene glycol (PEG), and identifying acrolein as a key pathological factor in spinal cord injury and multiple sclerosis.
Shi, along with retired Professor Richard Borgens and former Professor Andrew Blight, developed the Ampyra drug, the first and only FDA-approved drug to help multiple sclerosis patients improve their ability to walk and other motor skills.
Shi graduated from Shanghai Jiao Tong University and the University of North Texas before earning his PhD from Purdue in developmental neurobiology.
Source: Purdue Newsroom